ETHZilla Unveils New Brand Committed to Advancing Ethereum Treasury Strategy
ETHZilla Corporation (NASDAQ: ETHZ), formerly 180 Life Sciences Corp. (NASDAQ: ATNF), announced a major rebranding and strategic shift to focus on Ethereum treasury operations. The company's stock will begin trading under the new ticker ETHZ on August 18, 2025.
The company has successfully raised $565 million through private placements, including a $425 million PIPE and $156.25 million convertible note offering. ETHZilla has already accumulated 94,675 ETH at an average price of $3,902.20, currently valued at approximately $419 million, with an additional $187 million in cash equivalents.
Electric Capital will serve as the external asset manager, implementing an on-chain yield generation program combining staking, lending, and liquidity provisioning. The private placement attracted over 60 institutional and crypto-native investors, including prominent Ethereum ecosystem leaders.
ETHZilla Corporation (NASDAQ: ETHZ), precedentemente 180 Life Sciences Corp. (NASDAQ: ATNF), ha annunciato un importante rebranding e un cambio strategico per concentrarsi sulle operazioni di tesoreria in Ethereum. Le azioni della società inizieranno a essere negoziate con il nuovo ticker ETHZ il 18 agosto 2025.
La società ha raccolto con successo 565 milioni di dollari tramite collocamenti privati, inclusi un PIPE da 425 milioni di dollari e un offerta di note convertibili da 156,25 milioni di dollari. ETHZilla ha già accumulato 94.675 ETH a un prezzo medio di 3.902,20 $, attualmente valutati circa 419 milioni di dollari, con ulteriori 187 milioni di dollari in equivalenti di cassa.
Electric Capital agirà come asset manager esterno, implementando un programma on‑chain di generazione di rendimento che combina staking, prestito e fornitura di liquidità . Il collocamento privato ha attratto oltre 60 investitori istituzionali e nativi della criptovaluta, inclusi importanti leader dell'ecosistema Ethereum.
ETHZilla Corporation (NASDAQ: ETHZ), anteriormente 180 Life Sciences Corp. (NASDAQ: ATNF), anunció un importante cambio de marca y una reorientación estratégica para centrarse en las operaciones de tesorerÃa en Ethereum. Las acciones de la compañÃa comenzarán a cotizar con el nuevo ticker ETHZ el 18 de agosto de 2025.
La empresa ha recaudado con éxito 565 millones de dólares a través de colocaciones privadas, incluyendo un PIPE de 425 millones de dólares y una oferta de pagarés convertibles por 156,25 millones de dólares. ETHZilla ya ha acumulado 94.675 ETH a un precio medio de 3.902,20 $, valorados actualmente en aproximadamente 419 millones de dólares, con otros 187 millones de dólares en equivalentes de efectivo.
Electric Capital actuará como gestor de activos externo, implementando un programa on‑chain de generación de rendimiento que combina staking, préstamos y provisión de liquidez. La colocación privada atrajo a más de 60 inversores institucionales y nativos de cripto, incluidos destacados lÃderes del ecosistema Ethereum.
ETHZilla Corporation (NASDAQ: ETHZ)(êµ� 180 Life Sciences Corp., NASDAQ: ATNF)ëŠ� 대대ì ì¸ ë¦¬ë¸Œëžœë”©ê³� ì´ë”리움 재무 ìš´ì˜ì—� 집중하는 ì „ëžµì � ì „í™˜ì� 발표했습니다. 회사 주ì‹ì€ 2025ë…� 8ì›� 18ì¼ë¶€í„� 새로ìš� 티커 ETHZë¡� 거래ë¥� 시작합니ë‹�.
회사ëŠ� 사모ë¥� 통해 5ì–�6,500ë§� 달러ë¥� 성공ì 으ë¡� 조달했으ë©�, 여기ì—는 4ì–�2,500ë§� 달러 규모ì� PIPE와 1ì–�5,625ë§� 달러 규모ì� ì „í™˜ì‚¬ì±„ 발행ì� í¬í•¨ë©ë‹ˆë‹�. ETHZillaëŠ� ì´ë¯¸ í‰ê· ê°€ê²� 3,902.20달러ë¡� 94,675 ETHë¥� ì¶•ì 했으ë©�, 현재 ì•� 4ì–�1,900ë§� 달러 가치로 í‰ê°€ë˜ë©° 현금ì„� ìžì‚°ì� 추가ë¡� 1ì–�8,700ë§� 달러 있습니다.
Electric Capitalì� 외부 ìžì‚°ê´€ë¦¬ì‚¬ë¡� 참여í•� 스테ì´í‚¹, 대ì¶� ë°� ìœ ë™ì„� 공급ì� ê²°í•©í•� 온체ì� ìˆ˜ìµ ì°½ì¶œ 프로그램ì� ìš´ì˜í•� ì˜ˆì •ìž…ë‹ˆë‹�. ì� 사모ì—는 ì´ë”리움 ìƒíƒœê³„ì˜ ì£¼ìš” 리ë”ë“¤ì„ í¬í•¨í•� 60ê°� ì´ìƒì� 기관 ë°� í¬ë¦½í†� ì „ë¬¸ 투ìžìžê°€ 참여했습니다.
ETHZilla Corporation (NASDAQ: ETHZ), anciennement 180 Life Sciences Corp. (NASDAQ: ATNF), a annoncé un important rebranding et un recentrage stratégique sur les opérations de trésorerie en Ethereum. Les actions de la société commenceront à être négociées sous le nouveau ticker ETHZ le 18 août 2025.
La société a levé avec succès 565 millions de dollars via des placements privés, dont un PIPE de 425 millions de dollars et une émission de billets convertibles de 156,25 millions de dollars. ETHZilla a déjà accumulé 94 675 ETH à un prix moyen de 3 902,20 $, actuellement valorisés à environ 419 millions de dollars, avec en outre 187 millions de dollars en équivalents de trésorerie.
Electric Capital agira en tant que gestionnaire d'actifs externe, en mettant en œuvre un programme on‑chain de génération de rendement combinant staking, prêt et fourniture de liquidité. Le placement privé a attiré plus de 60 investisseurs institutionnels et natifs de la crypto, y compris des acteurs majeurs de l'écosystème Ethereum.
ETHZilla Corporation (NASDAQ: ETHZ), vormals 180 Life Sciences Corp. (NASDAQ: ATNF), hat ein umfassendes Rebranding und eine strategische Neuausrichtung angekündigt, um sich auf Ethereum-Treasury-Operationen zu konzentrieren. Die Aktien des Unternehmens werden ab dem 18. August 2025 unter dem neuen Ticker ETHZ gehandelt.
Das Unternehmen hat erfolgreich 565 Millionen US-Dollar durch Privatplatzierungen aufgenommen, darunter ein 425-Millionen-USD-PIPE und ein 156,25-Millionen-USD-Wandelanleihe-Angebot. ETHZilla hat bereits 94.675 ETH zu einem Durchschnittspreis von 3.902,20 $ akkumuliert, die derzeit mit rund 419 Millionen US-Dollar bewertet sind, zusätzlich zu 187 Millionen US-Dollar an Baräquivalenten.
Electric Capital wird als externer Asset Manager fungieren und ein On‑Chain-Ertragsprogramm umsetzen, das Staking, Kreditvergabe und Liquiditätsbereitstellung kombiniert. Die Privatplatzierung zog über 60 institutionelle und krypto‑native Investoren an, darunter führende Persönlichkeiten des Ethereum‑Ökosystems.
- Raised $565 million through successful private placements
- Accumulated 94,675 ETH valued at approximately $419 million
- Maintains strong cash position of $187 million in USD equivalents
- Secured backing from 60+ institutional and prominent crypto investors
- Partnership with Electric Capital for yield generation strategy
- Significant pivot from previous life sciences business model
- High concentration risk in single cryptocurrency asset (ETH)
- Average ETH acquisition price of $3,902.20 represents significant exposure to market volatility
Insights
ETHZilla's transition from biotech to Ethereum treasury with $419M in ETH represents a significant corporate pivot into crypto exposure for public markets.
This rebranding from 180 Life Sciences to ETHZilla marks a dramatic strategic pivot from biotech to becoming an Ethereum accumulation vehicle. The company has already deployed capital to acquire 94,675 ETH at an average price of
The successful fundraising of
ETHZilla's approach represents one of the first significant publicly-traded Ethereum treasury vehicles, creating a regulated pathway for traditional investors to gain Ethereum exposure without directly holding cryptocurrency. Their planned yield generation program managed by Electric Capital aims to outperform traditional ETH staking while maintaining risk management controls - a sophisticated approach compared to simple accumulation strategies.
This transition positions ETHZilla as an institutional on-ramp to Ethereum, potentially bridging traditional finance with decentralized finance. The company's substantial ETH position already represents meaningful market exposure, though its current trading price relative to its ETH holdings will be worth monitoring for potential premium or discount valuation metrics common to similar investment vehicles.
Company announces new ticker (formally ATNF) and will begin trading on NASDAQ under ETHZ on August 18, 2025
Company has accumulated 94,675 ETH at an average acquisition price of
Since the closing of the Company's previously disclosed
"Today, we are embracing our identity as ETHZilla and our commitment to developing a market-leading strategy that seeks to bring the value of Ethereum to investors in the public markets," said McAndrew Rudisill, Executive Chairman of the Board of Directors of the Company. "We are launching this new brand and our new treasury strategy with significant interest from the market and valuable partnerships with prominent Ethereum ecosystem founders and leaders."
Successful Private Placement & Convertible Note Expected to Ensure Next Phase of Growth
The rebrand to ETHZilla follows the successful closing of the Company's private placement and convertible note offering, which raised approximately
- Harbour Island;
- Electric Capital;
- Polychain Capital;
- GSR;
- Borderless Capital;
- Omicron Technologies;
- Konstantin Lomashuk (Co-Founder Lido and p2p.org);
- Sreeram Kannan (Founder, Eigenlayer);
- Mike Silagadze (Founder, Ether.fi);
- Danny Ryan (Co-Founder, Etherealize);
- Vivek Raman (Co-Founder, Etherealize);
- Sam Kazemanian (Co-Founder, Frax);
- Grant Hummer (Co-Founder of Etherealize);
- Robert Leshner (Founder, Compound and Superstate);
- Tarun Chitra (Founder, Gauntlet);
and several other prominent Ethereum ecosystem founders and leaders.Ìý
Capital Deployment Strategy Underway to Begin Significant ETH ´¡³¦³¦³Ü³¾³Ü±ô²¹³Ù¾±´Ç²ÔÌý
The Company has already begun allocating a significant portion of the net proceeds from the Private Placements for the purchase of ETH, provided the Company continues to support its iGaming operations and is working to monetize its legacy biotech intellectual property assets.
Electric Capital is serving as the external asset manager for ETHZilla, and plans to implement a differentiated, on-chain yield generation program designed with the goal of outperforming traditional ETH staking, while maintaining robust risk management, to leverage a combination of staking, lending, liquidity provisioning and bespoke private agreements.
About ETHZilla
ETHZilla is developing an accumulation vehicle for Ether (ETH), the native digital asset of Ethereum, that aims to become a benchmark for on-chain treasury management among public companies. This strategy will be built for the community, by the community.
Through its partnership with Electric Capital, ETHZilla's treasury strategy aims to pursue a differentiated yield generation program meant to outperform traditional ETH staking. The Company is supported by an executive team and DeFi Council that unites capital markets experts, prominent Ethereum engineers, top-tier DeFi founders, infrastructure pioneers and other ecosystem heavyweights.
The Company, originally formed as an innovative biotechnology company, has also been evolving its business towards software enabled gaming and entertainment. In addition to its ETH treasury strategy as discussed above, and its plans to monetize its existing legacy biotech assets, the Company continues to maintain and accelerate the deployment and development of its gaming initiatives.
Forward Looking Statements
This press release contains "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits of the Private Placements and related transactions, expectations regarding the capitalization, resources and ownership structure of the Company, the expected benefits of the Company's rebranding, expectations with respect to future performance, and growth of the Company; the ability of the Company to execute its plans, the Company's plans to continue to purchase ETH, the Company's digital asset treasury strategy, the digital assets to be held by the Company, anticipated yield strategies, and future performance. Forward looking statements are subject to numerous risks and uncertainties, many of which are beyond the Company's control, and actual results may differ materially. Applicable risks and uncertainties include, among others, the risk that the proposed transactions described herein may not be completed in a timely manner or at all; failure to realize the anticipated benefits of the PIPE, convertible notes, and related transactions, including the Company's recent digital asset treasury strategy; the Company's ability to achieve profitable operations; fluctuations in the market price of ETH that will impact the Company's accounting and financial reporting; government regulation of cryptocurrencies and online betting; changes in securities laws or regulations; changes in business, market, financial, political and regulatory conditions; risks relating to the Company's outstanding convertible notes, including the Company's ability to repay such notes, covenants associated therewith and dilution caused by the conversion thereof into common stock, and security interests associated therewith; risks relating to the Company's previously announced ATM offering, including potential downward pressure on the Company's stock price associated therewith; risks relating to the Company's operations and business, including the highly volatile nature of the price of Ether and other cryptocurrencies; the risk that the Company's stock price may be highly correlated to the price of the digital assets that it holds; risks related to increased competition in the industries in which the Company does and will operate; risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for
Media Contact:
Prosek Partners
pro-ETH@prosek.comÌý
Investor Contact:
Prosek Partners
[email protected]Ìý
View original content to download multimedia:
SOURCE ETHZilla Corporation